These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19758475)

  • 41. Effects of loud and amplified speech on sentence and word intelligibility in Parkinson disease.
    Neel AT
    J Speech Lang Hear Res; 2009 Aug; 52(4):1021-33. PubMed ID: 18978211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acoustic investigation of stress patterns in Parkinson's disease.
    Tykalova T; Rusz J; Cmejla R; Ruzickova H; Ruzicka E
    J Voice; 2014 Jan; 28(1):129.e1-129.e8. PubMed ID: 24094802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of experience on judgments of adductor spasmodic dysphonia.
    Eadie TL; Nicolici C; Baylor C; Almand K; Waugh P; Maronian N
    Ann Otol Rhinol Laryngol; 2007 Sep; 116(9):695-701. PubMed ID: 17926593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perception of clear fricatives by normal-hearing and simulated hearing-impaired listeners.
    Maniwa K; Jongman A; Wade T
    J Acoust Soc Am; 2008 Feb; 123(2):1114-25. PubMed ID: 18247912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Classification of dysphonic voice: acoustic and auditory-perceptual measures.
    Eadie TL; Doyle PC
    J Voice; 2005 Mar; 19(1):1-14. PubMed ID: 15766846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Scaling of voice pleasantness and acceptability in tracheoesophageal speakers.
    Eadie TL; Doyle PC
    J Voice; 2005 Sep; 19(3):373-83. PubMed ID: 16102664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of listening conditions and listener characteristics on intelligibility of dysarthric speech.
    Pennington L; Miller N
    Clin Linguist Phon; 2007 May; 21(5):393-403. PubMed ID: 17468997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Articulatory-acoustic vowel space: application to clear speech in individuals with Parkinson's disease.
    Whitfield JA; Goberman AM
    J Commun Disord; 2014; 51():19-28. PubMed ID: 25074511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The intelligibility of tracheoesophageal speech, with an emphasis on the voiced-voiceless distinction.
    Jongmans P; Hilgers FJ; Pols LC; van As-Brooks CJ
    Logoped Phoniatr Vocol; 2006; 31(4):172-81. PubMed ID: 17114130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of visual information on the intelligibility of dysarthric speech.
    Keintz CK; Bunton K; Hoit JD
    Am J Speech Lang Pathol; 2007 Aug; 16(3):222-34. PubMed ID: 17666548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical evaluation of Parkinson's-related dysphonia.
    Sewall GK; Jiang J; Ford CN
    Laryngoscope; 2006 Oct; 116(10):1740-4. PubMed ID: 17003722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of increased vocal intensity on interarticulator timing in speakers with Parkinson’s disease: a preliminary analysis.
    Richardson K; Sussman JE; Stathopoulos ET
    J Commun Disord; 2014; 52():44-64. PubMed ID: 25459460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of clear, loud, and slow speech on scaled intelligibility and speech severity in Parkinson's disease and multiple sclerosis.
    Tjaden K; Sussman JE; Wilding GE
    J Speech Lang Hear Res; 2014 Jun; 57(3):779-92. PubMed ID: 24687042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between acoustic measures and speech naturalness ratings in Parkinson's disease: A within-speaker approach.
    Klopfenstein M
    Clin Linguist Phon; 2015; 29(12):938-54. PubMed ID: 26403503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predicting Intelligibility Deficits in Parkinson's Disease With Perceptual Speech Ratings.
    Chiu YF; Neel A
    J Speech Lang Hear Res; 2020 Feb; 63(2):433-443. PubMed ID: 32097080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Comparative Study of Auditory-Perceptual Speech Measures for the Early Detection of Mild Speech Impairments.
    Kuruvilla-Dugdale M; Threlkeld K; Salazar M; Nolan G; Heidrick L
    Semin Speech Lang; 2019 Nov; 40(5):394-406. PubMed ID: 31426103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acoustic characteristics in relation to intelligibility reduction in noise for speakers with Parkinson's disease.
    Chiu Y; Neel A; Loux T
    Clin Linguist Phon; 2021 Mar; 35(3):222-236. PubMed ID: 32539544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Examining the relationship between speech intensity and self-rated communicative effectiveness in individuals with Parkinson's disease and hypophonia.
    Dykstra AD; Adams SG; Jog M
    J Commun Disord; 2015; 56():103-12. PubMed ID: 26188950
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clear Speech Variants: An Investigation of Intelligibility and Speaker Effort in Speakers With Parkinson's Disease.
    Stipancic KL; van Brenk F; Kain A; Wilding G; Tjaden K
    Am J Speech Lang Pathol; 2022 Nov; 31(6):2789-2805. PubMed ID: 36327495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of speakers' augmented characteristics and listeners' sex on intelligibility and acceptability of synthesized speech.
    Ellis LW; Spiegel B; Benjamin B
    Percept Mot Skills; 2002 Jun; 94(3 Pt 2):1081-8. PubMed ID: 12186228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.